Weei/nesn Jimmy Fund Radio-telethon

Dana Mohrlein, 35, astrocytoma, Niantic CT, with David Reardon, MD Clinical Director, Center of Neuro-Oncology, Dana-Farber In college, Dana thought she may have vertigo because of all her headaches, but after aseizure at her first security job, she learned she needed emergency brain surgery. After surgeryat her local hospital, she pursued a second opinion at Dana-Farber and has continued herjourney from there since. She had two additional brain surgeries that same summer atBrigham-Women's Hospital. Shortly after, she started high dose radiation locally, in partnershipwith Dana-Farber, and did 11 months of oral chemotherapy.· After treatment, 11 years passed until Dana had a recurrence last spring and underwenta fourth brain surgery. She now takes an inhibitor drug called Tibsovo, a medication specific toher mutation, that requires her to take two pills every day. The drug was released around thetime of Dana’s most recent recurrence, and she expresses it will hopefully be her “miraclemedicine” for the rest of